Recent literature review of Advanced Thyroid Management Beyond Optimization: Is It Safe To Use High Dose Optimization?:
Dr. Rouzier will be discussing: This review will demonstrate that the high circulating thyroid hormone levels resulting from HDT is fundamentally different than hyperthyroidism. High dose thyroid differs from hyperthyroidism in significant ways.
While hyperthyroidism is a significant cardiovascular risk factor causing a 20% premature death rate,
HDT treatment does not appear to be a significant cardiovascular risk.
The sequela of hyperthyroidism are increasing tied to autoimmune complications which are absent with HDT.
Equating hyperthyroidism with HDT is incorrect.
The first myth is that HDT is a risk factor for developing osteoporosis and the second myth is that HDT increases cardiovascular risk.
The cardiovascular risks of HDT appear to be low.
HDT is at least as safe as or safer than many psychiatric medications. It is effective and well tolerated.
This inaccuracy has been promulgated by the chronic misuse of terminology (i. e. calling all suppressed TSH or elevations of thyroid hormones hyperthyroidism) in the literature there is at best confusion about the difference between HDT and hyperthyroidism.
At worst there is remarkably resolute conviction that there is no difference.
To sum, the use of HDT is not equivalent to hyperthyroidism. .
About the Speaker
Dr. Neal Rouzier specializes in the medical management of aging and preventive care, who has dedicated his life’s work to uncovering the medical literature that supports Bio Identical Hormone Replacement Therapy. He has revealed over 50 years of scientific evidence regarding the impact that hormone levels have on physical health, mental health and overall quality of life. As the lead instructor of Worldlink Medical, he teaches Physicians and Practitioners the protocols for safe and effective use of Hormones as Preventive Medicine. He has over 16 years of experience as an educator and practicing physician.